BioSpace News Archive

Aulos Bioscience today announced a new collaboration and supply agreement with Ares Trading S.A., a Swiss subsidiary of Merck KGaA, Darmstadt, Germany, for use of Bavencio® (avelumab) in a clinical study of its lead human monoclonal antibody candidate, AU-007.

Aspen Neuroscience, Inc. has received a CLIN2 grant award of $8 million from the California Institute for Regenerative Medicine (CIRM), the world’s largest institution dedicated to regenerative medicine, to support clinical research aimed at treating Parkinson’s disease (PD).

Infinimmune announced today the appointment of a new independent director, Neela Patel, Ph.D., to the company’s Board of Directors.

Aphios Corporation announced today that it has been granted US Patent No. 11,981,174 for CCR5 and CD4 siRNA-targeted therapeutics for treatment of HIV-1 and other diseases.

Bausch Health Companies Inc. announced the results of its 2024 annual meeting of shareholders.

Veru Inc. announced Steven B. Heymsfield, M.D., a Professor and the Director of the Body Composition-Metabolism Laboratory at the Pennington Biomedical Research Center in Baton Rouge, Louisiana, as the Principal Investigator for the Company’s Phase 2b clinical trial of enobosarm to preserve muscle while augmenting fat loss in patients receiving a GLP-1 RA for weight loss.

Yield10 Bioscience, Inc., an agricultural bioscience company, announced that Company has received a final delisting notice from Nasdaq.

Adial Pharmaceuticals, Inc. today provided a business update and reported its financial results for the first quarter of 2024.

Photocure ASA reported Hexvix®/Cysview® revenues of NOK 116.8 million in the first quarter of 2024, and EBITDA of NOK 7.9 million following positive operational developments and cost control.

Evotec SE will announce its financial results for the first quarter of 2024 on Wednesday, 22 May 2024.